Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Ovarian Neoplasms 69Fallopian Tube Neoplasms 18Endometrial Neoplasms 8Carcinoma, Ovarian Epithelial 8Breast Neoplasms 7Neoplasms 5Pancreatic Neoplasms 3Cystadenocarcinoma, Serous 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Urogenital Neoplasms 2Prostatic Neoplasms 2Ovarian Diseases 2Neoplasm Metastasis 2Gonadal Disorders 2Genital Neoplasms, Female 2Genital Diseases, Female 2Endocrine System Diseases 2Endocrine Gland Neoplasms 2Carcinoma 2Adnexal Diseases 2Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocytopenia 1Sarcoma 1Recurrent/ Advanced Stage Endometrial Cancer Patients 1Recurrence 1Prostatic Diseases 1Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1Platinum-resistant Ovarian Cancer 1

Interventions

fludarabine 4aldesleukin 4Cyclophosphamide 4pembrolizumab 3niraparib 2Riluzole 2olaparib 1motexafin gadolinium 1lenvatinib 1anlotinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Specimen Handling 1Remote Patient Monitoring 1Pregnancy Tests 1Pemetrexed 1Paclitaxel 1Ocoxin 1Loperamide 1Imagery, Psychotherapy 1Human Papillomavirus DNA Tests 1Genetic Testing 1Fulvestrant 1Filgrastim 1Fecal Microbiota Transplantation 1Educational Status 1Drug Therapy 1Diffusion 1Colposcopy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urogenital Neoplasms × niraparib × Gynecologic × Clear all
NCT04556071 2020-11-10

AVANIRA3

Jiangsu Cancer Institute & Hospital

Phase 2 Unknown
32 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Adnexal Diseases, Carcinoma, Endocrine System Diseases, Endocrine Gland Neoplasms, Fallopian Tube Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Gonadal Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

NCT00749502 2013-07-25

A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)

Tesaro, Inc.

Phase 1 Completed
113 enrolled
GenitourinaryGynecologicLymphoidOther hematologic neoplasm

Adnexal Diseases, Endocrine System Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Genital Diseases, Male, Genital Neoplasms, Female, Genital Neoplasms, Male, Gonadal Disorders, Neoplasms, Ovarian Diseases, Ovarian Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡